Hunan, CHN
Jie Liu is a Ph.D. Candidate in Critical Care Medicine at Xiangya Hospital, Central South University. His doctoral research is primarily focused on investigating the pathogenesis of septic cardiomyopathy, where he seeks to elucidate the underlying molecular mechanisms driving this serious condition. Through his work, he aims to contribute to the development of improved diagnostic strategies and therapeutic interventions for sepsis patients.
The Dichotomous Role of Ankrd1 in Septic Cardiomyopathy: Protective or Detrimental?
Monday, March 23, 2026
2:30 PM - 3:30 PM Central Time
Disclosure(s): No relevant financial relationship(s) to disclose.
Targeting ATF4-DDIT4/TXNIP-Induced Ferroptosis: ISRIB as Novel Therapy for Septic Cardiomyopathy
Monday, March 23, 2026
2:30 PM - 3:30 PM Central Time
Disclosure(s): No relevant financial relationship(s) to disclose.
The Cardiac Protective Role of Vav3 in Septic Cardiomyopathy via Modulating Calcium Homeostasis
Tuesday, March 24, 2026
11:15 AM - 12:15 PM Central Time
Disclosure(s): No relevant financial relationship(s) to disclose.
